Expansion of the SPD business and promotion of medical materials management services
First written in FY2016. 18 of 29 entries say "Restated". Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「By combining various solution tools, including a logistics management system, the operating-room support program "ＳＵＲＧＥＬＡＮＥ®," and the material-price optimisation support system "ｍｅｃｃｕｌ®," built on "ASOURCE® DATABASE," one of Japan's largest medical-materials databases independently developed by a subsidiary of the Company,」
In addition to its conventional SPD and medical supplies management services, the company explicitly describes a structure combining multiple solutions built on what it calls one of Japan's largest medical supplies databases. - FY2024RestatedAnnual report
「The Group conducts its business activities based on a policy of ensuring a stable supply of products and addressing customer issues in order to help establish a sustainable healthcare system.」
The Company continues to pursue a strategy based on medical-materials sales and management services, including SPD and operating-room-related products, focused on stable supply and resolving customer issues. - FY2024-Q1RestatedAnnual report
「Sales of operating-room-related products and other products were strong as medical demand recovered compared with the same quarter of the previous year.」
The Company states that sales of operating-room-related products and other products were strong against a backdrop of recovering medical demand, and continues to pursue medical-materials management and sales services, including operating-room-related products. - FY2023-Q3RestatedAnnual report
「Sales and gross profit increased year on year, owing in part to sales related to SPD contracts obtained in the previous fiscal year and increased share among existing customers.」
The Company states that sales related to SPD contracts obtained in the previous fiscal year contributed to higher revenue and continues to promote medical-materials management services through the SPD business. - FY2022AdvancedAnnual report
「The Company also actively promoted proposals for solutions contributing to the medical environment and improvements in management. The acquisition of new SPD contracts also contributed to higher revenue in the medical-equipment sales business.」
The Company identifies the acquisition of new SPD contracts and its contribution to higher revenue in the medical-equipment sales business as a full-year result. - FY2022-Q3RestatedAnnual report
「The impact of the decline in surgical cases caused by the COVID-19 pandemic was showing signs of recovery, sales of operating-room-related products increased, sales of infection-control consumables remained strong, and SPD and the acquisition of new customers also contributed to year-on-year increases in net sales and gross profit for consumables in the medical-equipment sales business.」
The Company continues to describe the expansion of consumables sales through SPD and the acquisition of new customers. - FY2022-Q2RestatedAnnual report
「The impact of the decline in surgical cases caused by the COVID-19 pandemic was showing signs of recovery. Sales of operating-room-related products increased, and, together with SPD and the acquisition of new customers, this resulted in year-on-year increases in net sales and gross profit for consumables in the medical-equipment sales business.」
The Company continues to describe the expansion of consumables sales through SPD and the acquisition of new customers. - FY2022-Q1RestatedAnnual report
「Although sales of consumables in the medical-equipment sales business were affected by a decline in surgical cases resulting from the spread of COVID-19, net sales and gross profit increased year on year owing to SPD and the acquisition of new customers.」
The Company continues to describe the expansion of consumables sales through SPD and the acquisition of new customers. - FY2021-Q3RestatedAnnual report
「Although sales of consumables in the medical-equipment sales business were affected by a decline in surgical cases resulting from the spread of COVID-19, sales and gross profit increased year on year because of higher sales following the acquisition of SPD contracts and new customers, the establishment of new sales offices, and the integration with ㈱アクティブメディカル.」
The Company continues to describe increased consumables sales through SPD, new-customer acquisition, the establishment of new sales offices and the business integration with アクティブメディカル. - FY2021-Q2RestatedAnnual report
「Although sales of consumables in the medical-equipment sales business were affected by a decline in surgical cases resulting from the spread of COVID-19, sales and gross profit increased year on year because of higher sales following the acquisition of SPD contracts and new customers, the establishment of new sales offices, and the integration with ㈱アクティブメディカル.」
The Company continues to describe increased consumables sales from SPD, new-customer acquisition and the establishment of new sales offices, together with the effects of the business integration. No additional milestones such as a new contract count are presented. - FY2021-Q1AdvancedAnnual report
「Although sales of consumables in the medical-equipment sales business were affected by a decline in surgical cases resulting from the spread of COVID-19, sales and gross profit increased year on year because of higher sales following the acquisition of SPD contracts and new customers, the establishment of new sales offices, and the integration with ㈱アクティブメディカル.」
The disclosure states that acquiring new SPD contracts and new customers and establishing new sales offices led to increased consumables sales. - FY2020RestatedAnnual report
「By combining various solution tools, including a logistics management system, the operating-room support program "ＳＵＲＧＥＬＡＮＥ," the material-price optimisation support system "ｍｅｃｃｕｌ®," and the operating-room information management system "ＭＯＲＩＳＳ,"」
The Company continues to promote integrated medical-materials management services based on SPD, including operating-room support, material-price optimisation and information management. - FY2020-Q2RestatedAnnual report
「Sales and gross profit of consumables in the medical-equipment sales business increased year on year, owing to increased sales under newly acquired SPD contracts, an increase in surgical cases and front-loaded demand ahead of the consumption-tax increase.」
The Company continues to describe expanded consumables sales through new SPD contracts, an increase in surgical cases and front-loaded demand. - FY2019AdvancedAnnual report
「The Company focused particularly on expanding the SPD business. Through sales of medical materials (consumables), it promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "ＳＵＲＧＥＬＡＮＥ," the medical-materials database and analysis service "ｍｅｃｃｕｌ®," and the operating-room information management system "ＭＯＲＩＳＳ" for managing operating-room supplies. As a result, although equipment sales were sluggish compared with the previous fiscal year because large projects associated with capital investment declined, total sales exceeded the previous fiscal year because sales of medical materials (consumables) remained firm following the acquisition of new SPD contracts.」
The acquisition of new SPD contracts kept medical-materials sales firm and helped total sales exceed the previous fiscal year. - FY2019-Q3RestatedAnnual report
「Sales of consumables in the medical-equipment sales business remained firm, owing not only to higher revenue from the business integration but also to increased sales under newly acquired SPD contracts in existing areas.」
The Company continues to describe increased consumables sales through the business integration and new SPD contracts in existing areas. No additional milestones such as a new contract count are presented. - FY2019-Q2RestatedAnnual report
「Sales of consumables in the medical-equipment sales business remained firm, owing not only to higher revenue from the business integration but also to increased sales under newly acquired SPD contracts in existing areas.」
The Company continues to describe the initiative of acquiring new SPD contracts in existing areas, in addition to the business integration, to increase consumables sales. Similar new contract acquisitions had also been disclosed through the previous quarter, and no additional milestones such as a new contract count are presented. - FY2019-Q1AdvancedAnnual report
「Sales of consumables in the medical-equipment sales business remained firm, owing not only to higher revenue from the business integration but also to increased sales under newly acquired SPD contracts in existing areas.」
In addition to the business integration, the Company acquired new SPD contracts in existing areas and increased consumables sales, which it identifies as progress during the quarter. - FY2018AdvancedAnnual report
「The Company focused particularly on expanding the SPD business. Through sales of medical materials (consumables), it promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "ＳＵＲＧＬａｎｅ®," the medical-materials database and analysis service "ｍｅｃｃｕｌ®," and the operating-room information management system "ＭＯＲＩＳＳ" for managing operating-room supplies. As a result, although equipment sales were sluggish compared with the previous fiscal year because large projects associated with capital investment declined, total sales exceeded the previous fiscal year because sales of medical materials (consumables) remained firm following the acquisition of new SPD contracts.」
The acquisition of new SPD contracts kept medical-materials sales firm and helped total sales exceed the previous fiscal year. - FY2018-Q3RestatedAnnual report
「We focused particularly on expanding the SPD business. Through sales of medical materials (consumables), we promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "ＳＵＲＧＬａｎｅ®," the medical-materials database and analysis service "ｍｅｃｃｕｌ®," and the operating-room information management system "ＭＯＲＩＳＳ" for managing operating-room supplies.」
The Company continues to describe the expansion of the SPD business and the promotion of integrated services comprising operating-room support, a medical-materials database and analysis, and an operating-room supply-management system. No explicit additional milestones, such as a new contract count, are disclosed. - FY2018-Q2RestatedAnnual report
「We focused particularly on expanding the SPD business. Through sales of medical materials (consumables), we promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "ＳＵＲＧＬａｎｅ®," the medical-materials database and analysis service "ｍｅｃｃｕｌ®," and the operating-room information management system "ＭＯＲＩＳＳ" for managing operating-room supplies.」
The Company continues to describe the expansion of the SPD business and the promotion of integrated services comprising operating-room support, a medical-materials database and analysis, and an operating-room supply-management system. - FY2018-Q1AdvancedAnnual report
「We focused particularly on expanding the SPD business. Through sales of medical materials (consumables), we promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "ＳＵＲＧＬａｎｅ®," the medical-materials database and analysis service "ｍｅｃｃｕｌ®," and the operating-room information management system "ＭＯＲＩＳＳ" for managing operating-room supplies. As a result, although equipment sales were sluggish compared with the same quarter of the previous year because large projects associated with capital investment declined in all but certain regions, total sales exceeded the same quarter of the previous year because sales of medical materials (consumables) remained firm following the acquisition of new SPD contracts.」
The Company identifies the acquisition of a new SPD contract during the quarter and the resulting firm sales of medical materials as specific progress. - FY2017AdvancedAnnual report
「As a result, although sales of equipment were sluggish compared with the previous fiscal year because large projects associated with capital investment declined in all but certain regions, sales exceeded the previous fiscal year overall because sales of medical materials (consumables) remained firm following the acquisition of new SPD contracts.」
The Company identifies the acquisition of new SPD contracts and the resulting increase in consumables sales as specific progress for the full fiscal year. - FY2017-Q3RestatedAnnual report
「We focused particularly on expanding the SPD business. Through sales of medical materials (consumables), we promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "サージレーン," the medical-materials database and analysis service "メッカル," and the operating-room information management system "MORISS" for managing operating-room supplies.」
The Company reiterates the expansion of the SPD business and the promotion of integrated services comprising operating-room support, a medical-materials database and analysis, and an operating-room supply-management system. - FY2017-Q2RestatedAnnual report
「We focused particularly on expanding the SPD business. Through sales of medical materials (consumables), we promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "サージレーン," the medical-materials database and analysis service "メッカル," and the operating-room information management system "MORISS" for managing operating-room supplies.」
The Company reiterates the expansion of the SPD business and the promotion of integrated services comprising operating-room support, a medical-materials database and analysis, and an operating-room supply-management system. No additional milestones, such as a new contract count, are disclosed. - FY2017-Q1AdvancedAnnual report
「We focused particularly on expanding the SPD business. Through sales of medical materials (consumables), we promoted integrated services that can improve the management of medical institutions, including proposals for the operating-room support software "サージレーン," the medical-materials database and analysis service "メッカル," and the operating-room information management system "MORISS" for managing loaned operating-room supplies.」
The Company reiterates its policy of expanding the SPD business and describes an increase in the sales base for consumables under newly acquired SPD contracts, indicating progress in acquiring specific contracts. - FY2016First statedAnnual report
「The Group placed particular emphasis on expanding its SPD business. Through sales of medical materials and consumables, it promoted integrated services that contribute to improving the management of medical institutions, including proposals for the operating-room support software “SURGLane,” the medical materials database and analysis service “meccul,” and the operating-room information management system “MORISS” for managing loaned equipment.」
SPD is being developed not merely as a consumables distribution business, but as an integrated service combining operating-room support, database and analytics functions, and loaned-equipment management.